Also of interest was the decreased expression of Drd1a, Crhr1, Grm5. Its altered activity has been associated with various human neurological disorders including schizophrenia, Alzheimer's disease and Huntington's disease. This evidence concerns the gene GRM5 and early-onset autosomal dominant Alzheimer disease.